ADAMTSL4
protein-codingADAMTS like 4, the group of ADAMTS like|MicroRNA protein coding host genes
Gene summary
This gene is a member of ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs)-like gene family and encodes a protein with seven thrombospondin type 1 repeats. The thrombospondin type 1 repeat domain is found in many proteins with diverse biological functions including cellular adhesion, angiogenesis, and patterning of the developing nervous system. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Sep 2014]
- TSRC1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~11.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009152
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009153
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0015998
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009152
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009152
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009153
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Clinical Genomic Database (CGD)
Manifestation: Ophthalmologic
Intervention: Ophthalmologic; Pharmacogenomic
Rationale: Although management related to some manifestations may be made through clinical observations (eg, related to amblyopia), surveillance related to intraocular pressure monitoring may be beneficial to allow prompt interventions; preventive measures (eg, related to contact sports) may be beneficial; Agents that may contribute to glaucoma should be avoided
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ADAMTSL4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_019032.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 406 | 5 | 420 | ||
| missense | 1 | 4 | 493 | 36 | 4 | 538 |
| nonsense | 46 | 13 | 59 | |||
| start loss | 1 | 1 | ||||
| frameshift | 76 | 24 | 4 | 104 | ||
| splice donor/acceptor (+/-2bp) | 2 | 21 | 1 | 24 | ||
| Total | 125 | 63 | 507 | 442 | 9 | 1146 |
Highest pathogenic variant AF is 0.001757404
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_061905.2 | 17 | MANE Select | |
| Ensembl | ENSP00000271643.4 | 17 | MANE Select | |
| RefSeq | NP_001275536.1 | 18 | Standard | |
| RefSeq | NP_001275537.1 | 18 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Post-translational protein modification
- Metabolism of proteins
- O-glycosylation of TSR domain-containing proteins
- O-linked glycosylation
Biological Process
- epithelial cell development
- proteolysis
- apoptotic process
- extracellular matrix organization
- positive regulation of apoptotic process
Molecular Function
- protease binding
- protein binding
- peptidase activity
Cellular Component
- cellular_component
- interstitial matrix
- endoplasmic reticulum lumen
- collagen-containing extracellular matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000271643
- Coding exons
- 17
- Length
- 11530
- Individuals with no LoFs
- 125228
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 519
- Defined
- 125748
- p
- 0.00207
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0800 | 666 | 672 | 0.991 | 0.0000450 | 6801 |
| Missense (PolyPhen) | 251 | 255.98 | 0.98055 | 2556 | ||
| Synonymous | 0.337 | 259 | 266 | 0.974 | 0.0000166 | 2357 |
| Loss of Function | 0.979 | 47 | 54.8 | 0.857 | 0.00000316 | 534 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0023 | 0.0022 | notable |
| Latino/Admixed American | 0.00091 | 0.00090 | rare |
| Ashkenazi Jewish | 0.00040 | 0.00040 | rare |
| East Asian | 0.00083 | 0.00082 | rare |
| Finnish | 0.0021 | 0.0021 | notable |
| European (Non-Finnish) | 0.0032 | 0.0031 | notable |
| South Asian | 0.00079 | 0.00078 | rare |
| Other | 0.0018 | 0.0018 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Positive regulation of apoptosis. May facilitate FBN1 microfibril biogenesis. {ECO:0000269|PubMed:16364318, ECO:0000269|PubMed:21989719}.;
- Disease
- DISEASE: Ectopia lentis 2, isolated, autosomal recessive (ECTOL2) [MIM:225100]: An ocular abnormality characterized by partial or complete displacement of the lens from its space resulting from defective zonule formation. {ECO:0000269|PubMed:19200529}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ectopia lentis et pupillae (ECTOLP) [MIM:225200]: An ocular abnormality characterized by displacement of the lenses and the pupils, associated with other ocular anomalies, but without systemic manifestations. The condition is usually bilateral, with the lenses and pupils displaced in opposite directions. Additional signs include enlarged corneal diameter, increased corneal astigmatism, increased anterior chamber depth, thinning and flattening of the iris with loss of crypts, angle malformation caused by enlarged iris processes, persistent pupillary membrane, loss of zonular fibers, tilted disk, and increased axial length. Secondary manifestations include refractive errors, glaucoma, early cataract development, and retinal detachment. Membrane formation on the posterior aspect of the iris has been observed both in histologic sections and on ultrasound biomicroscopy. {ECO:0000269|PubMed:20702823}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0987
Intolerance Scores
- LoFtool
- 0.989
- RVIS EVS
- 0
- RVIS percentile EVS
- 53.51
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.853
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |